News

Intrepid Recovery Center Unveils Innovative Partial Hospitalization Program (PHP) in West Palm Beach, Florida

Intrepid Recovery Center's Founder, John Nash Pakel, Champions the Next Phase in Addiction Treatment with the Introduction of PHP -…

1 year ago

Research Shows Cooking Classes Have Positive Impact on Participants’ Microbiome

A University of Chicago team is exploring how a series of cooking classes, focused on nutrition and making better food…

1 year ago

Rocket Doctor and Engagewell IPA Win New York Health Foundation Grant to Expand ‘Healthcare in Housing’ for Residents in Inner-City NY

Partnership Lets Patients in Supportive Housing Access Comprehensive Virtual Primary Care and Mental Health Services, Powered by Device Kiosks and…

1 year ago

Dr. Amy MacIntyre, MD: A Beacon of Expertise in Child & Adolescent Psychiatry Featured in Health Benefits Times Article

BRYN MAWR, PA / ACCESSWIRE / November 29, 2023 / Dr. Amy MacIntyre, MD, a distinguished child and adolescent psychiatry…

1 year ago

Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder

VANCOUVER, BC / ACCESSWIRE / November 29, 2023 / Clairvoyant Therapeutics Inc. (www.clairvoyantrx.com), the clinical-stage pharmaceutical company developing psilocybin therapy…

1 year ago

SELLAS Life Sciences Reaches Target Enrollment ex-China in Phase 3 REGAL Trial of Galinpepimut-S in Acute Myeloid Leukemia

Independent Data Monitoring Committee Scheduled to Meet This QuarterNEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group,…

1 year ago

BayMark Releases Whitepaper: 2023 Nationwide Opioid Use Disorder Treatment Outcomes Report

BayMark's Study Demonstrates the Path to More Successful Opioid Use Disorder TreatmentLEWISVILLE, Texas, Nov. 29, 2023 (GLOBE NEWSWIRE) -- BayMark,…

1 year ago

Alpha Tau to Participate in Sidoti Small-Cap Conference

JERUSALEM, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the…

1 year ago

Mangoceuticals Selects TRYBE Labs as its Nationwide Blood Collection and Testing Services Provider

TRYBE Labs to provide MangoRx customers with turnkey at-home blood collection services and solutions Dallas, Texas, Nov. 29, 2023 (GLOBE…

1 year ago

Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate

Primary endpoint met Demonstrated safety and reactogenicity of DYAI-100 recombinant proteinC1-cell produced antigen was both safe and well-toleratedNo Serious Adverse…

1 year ago